Zhong Ou AMC

Dou Yuming has led Zhong Ou AMC as a central figure since shortly after its 2013 founding, overseeing its evolution from a public-equity manager into a multi-strategy firm. The investment committee structure draws on both the Generali seconded expertise and locally recruited portfolio managers. Specific allocation authority by asset class is not publicly detailed.

Zhong Ou AMC was formed as a joint venture with Generali holding majority ownership, a structure permitted under China's gradual liberalization of its asset management sector. This foreign-majority model subjects the firm to both domestic Chinese securities regulation and cross-border governance standards. Its fund products are distributed primarily to mainland Chinese investors through local banking and brokerage channels (public record).

The firm targets early-stage and growth-stage venture investments, with a focus on sectors including healthcare, advanced manufacturing, and technology. It allocates through direct equity stakes and commitments to external venture capital funds. The geographic emphasis remains heavily tilted toward mainland China, where the firm's origination networks are deepest.

Zhong Ou AMC operates a hybrid model that includes direct equity investments in private companies alongside commitments to external venture capital funds. This dual approach allows the firm to access proprietary deal flow while also gaining diversified exposure through seasoned local fund managers in specialist sectors (per the firm's official communications).

Public disclosures and portfolio activity indicate a primary concentration in healthcare, advanced manufacturing, and technology. The firm aligns its sector focus with Chinese state-guided industrial priorities, where policy tailwinds support capital formation in semiconductor, biotech, and clean manufacturing sub-sectors.